StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Earnings

Panacea Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Panacea Life Sciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2019ended Sep 30, 2019Nov 14, 2019during market hours–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Panacea Life Sciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Panacea Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Panacea Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?